YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.

Honghai DaiYang W ShaoXiaoling TongXue WuJiaohui PangAlei FengZhe Yang

Published in: Cancer medicine (2019)

The results suggested that YAP1 amplification is a potentially useful biomarker for predicting treatment outcomes and identifying patients with a high risk of relapse who should be closely monitored.

Keyphrases

prognostic factors
nucleic acid
locally advanced
rectal cancer
label free
squamous cell carcinoma
radiation therapy